AUROBINDO PHARMA USA
Quick facts
Marketed products
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about AUROBINDO PHARMA USA
What are AUROBINDO PHARMA USA's marketed drugs?
Top marketed products include DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE.
Related
- DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE · Other
- Sector hub: All tracked pharma companies